Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUROSUMAB vs BUTENAFINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUROSUMAB vs BUTENAFINE: Safety Overview

Metric BUROSUMAB BUTENAFINE
Total FAERS Reports 674 768
Deaths Reported 6 0
Death Rate 0.9% N/A
Hospitalizations 111 4
Average Patient Age 37.3 yrs 59.8 yrs
% Female Patients 50.0% 46.9%
FDA Approval Date N/A Dec 7, 2001
Manufacturer Kyowa Kirin, Inc. Kroger Company
Route SUBCUTANEOUS TOPICAL
Marketing Status N/A Discontinued